Switch theme
Sign up to access all valuation multiples
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
2000
2
Last FY Revenue $10.4M
Last FY EBITDA -$30.7M
$30.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Aqua Bio Technology achieved revenue of $10.4M and an EBITDA of -$30.7M.
Aqua Bio Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Aqua Bio Technology valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $10.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 2% | XXX | XXX | XXX |
| EBITDA | XXX | -$30.7M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -295% | XXX | XXX | XXX |
| EBIT | XXX | -$12.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | -115% | XXX | XXX | XXX |
| Net Profit | XXX | -$33.0M | XXX | XXX | XXX |
| Net Margin | XXX | -317% | XXX | XXX | XXX |
| Net Debt | XXX | $12.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Aqua Bio Technology's stock price is NOK 1 (or $0).
Aqua Bio Technology has current market cap of NOK 119M (or $11.7M), and EV of NOK 308M (or $30.1M).
See Aqua Bio Technology trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30.1M | $11.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Aqua Bio Technology has market cap of $11.7M and EV of $30.1M.
Aqua Bio Technology's trades at 2.9x EV/Revenue multiple, and -1.0x EV/EBITDA.
Equity research analysts estimate Aqua Bio Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aqua Bio Technology's P/E ratio is not available.
See valuation multiples for Aqua Bio Technology and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $11.7M | XXX | $11.7M | XXX | XXX | XXX |
| EV (current) | $30.1M | XXX | $30.1M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -2.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAqua Bio Technology's revenue per employee in the last FY averaged $5.2M, while opex per employee averaged $6.1M for the same period.
Aqua Bio Technology's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aqua Bio Technology's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aqua Bio Technology and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -295% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $5.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $6.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 117% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aqua Bio Technology acquired XXX companies to date.
Last acquisition by Aqua Bio Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . Aqua Bio Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Aqua Bio Technology founded? | Aqua Bio Technology was founded in 2000. |
| Where is Aqua Bio Technology headquartered? | Aqua Bio Technology is headquartered in Norway. |
| How many employees does Aqua Bio Technology have? | As of today, Aqua Bio Technology has 2 employees. |
| Is Aqua Bio Technology publicy listed? | Yes, Aqua Bio Technology is a public company listed on OSL. |
| What is the stock symbol of Aqua Bio Technology? | Aqua Bio Technology trades under ABTEC ticker. |
| When did Aqua Bio Technology go public? | Aqua Bio Technology went public in 2008. |
| Who are competitors of Aqua Bio Technology? | Similar companies to Aqua Bio Technology include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Aqua Bio Technology? | Aqua Bio Technology's current market cap is $11.7M |
| Is Aqua Bio Technology profitable? | Yes, Aqua Bio Technology is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
